Page last updated: 2024-08-24

cephalosporin c and Chronic Kidney Diseases

cephalosporin c has been researched along with Chronic Kidney Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Fong Voon, K; Jan, TH; Kamaruzaman, L; Mohd, R; Muniandy, G; Mustafar, R; Neesam, MT; Pau Kiew, B1
Echols, R; Katsube, T; Kawaguchi, N; Wajima, T1
Bathini, L; Battistella, M; Garg, AX; Jain, AK; Jandoc, R; Kuwornu, P; Liu, A; McArthur, E; Muanda, FT; Sood, MM; Weir, MA1
Clark, SL; Fugate, JE; Hocker, SE; Kalimullah, EA; Rabinstein, AA; Wijdicks, EF1
Ambrose, PG; Bhavnani, SM; Critchley, IA; Friedland, HD; Khariton, T; Riccobene, TA; Rubino, CM; Van Wart, SA1
Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC1
Honore, PM; Spapen, HD1
Chuard, C; Descombes, E; Erard, V; Hemett, OM; Martins, F1
Gomolin, IH; Lam, S1

Reviews

1 review(s) available for cephalosporin c and Chronic Kidney Diseases

ArticleYear
Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Pharmacotherapy, 2006, Volume: 26, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Electroencephalography; Female; Humans; Myoclonus; Neurotoxicity Syndromes; Renal Insufficiency, Chronic; Urinary Tract Infections

2006

Trials

1 trial(s) available for cephalosporin c and Chronic Kidney Diseases

ArticleYear
Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Case-Control Studies; Cefiderocol; Cephalosporins; Creatinine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Pyelonephritis; Renal Insufficiency, Chronic; Severity of Illness Index; Siderophores; Urinary Tract Infections

2018

Other Studies

7 other study(ies) available for cephalosporin c and Chronic Kidney Diseases

ArticleYear
Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.
    Acta medica Indonesiana, 2023, Volume: 55, Issue:1

    Topics: Anti-Bacterial Agents; Brain Diseases; Cefepime; Cephalosporins; Female; Humans; Middle Aged; Renal Insufficiency, Chronic

2023
Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.
    Clinical journal of the American Society of Nephrology : CJASN, 2019, 02-07, Volume: 14, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefprozil; Cefuroxime; Cephalexin; Cephalosporins; Databases, Factual; Emergency Service, Hospital; Female; Glomerular Filtration Rate; Hospitalization; Humans; Male; Mortality; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Failure

2019
Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Critical care (London, England), 2013, Nov-07, Volume: 17, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Consciousness Disorders; Delirium; Female; Humans; Intensive Care Units; Male; Medical Records; Minnesota; Myoclonus; Neurotoxicity Syndromes; Renal Insufficiency, Chronic; Retrospective Studies

2013
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Humans; Mice; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Renal Insufficiency, Chronic; Severity of Illness Index; Staphylococcus aureus; Streptococcus pneumoniae

2014
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome

2015
Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
    Critical care (London, England), 2015, Dec-30, Volume: 19

    Topics: Cephalosporins; Consciousness Disorders; Delirium; Female; Humans; Male; Myoclonus; Neurotoxicity Syndromes; Renal Insufficiency, Chronic

2015
Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.
    BMC pharmacology & toxicology, 2016, Feb-04, Volume: 17

    Topics: Aged; Anti-Bacterial Agents; Anuria; Cefepime; Cephalosporins; Cohort Studies; Drug Administration Schedule; Drug Monitoring; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Renal Dialysis; Renal Elimination; Renal Insufficiency, Chronic; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus

2016